abstract |
The present invention relates to genomic regions which are useful markers for determining whether a subject is suffering from inflammatory bowel disease, such as ulcerative colitis or Crohn's disease, or is healthy. The invention also provides primers useful for measuring expression levels of said markers, as well as computer-implemented methods. |